MSE
ABBV icon

MUFG Securities EMEA’s AbbVie ABBV Stock Holding History

MUFG Securities EMEA’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-250,000
Closed -$14.6M – 111
2015
Q1 		$14.6M Buy
+250,000
New +$15.1M 3.8% 7

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MUFG Securities EMEA's ABBV Position: Q2 2026 in Review

MUFG Securities EMEA reduced its AbbVie (ABBV) stake by 84% in Q2 2026, selling an estimated $78.2M and leaving 69,153 shares worth $17.4M. The position accounts for 0.18% of the portfolio, ranked #96.

MUFG Securities EMEA first reported a position in ABBV in Q2 2015 and has held it in 23 quarters since. The position peaked at $94.1M in Q1 2026. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MUFG Securities EMEA held 69,153 shares of AbbVie worth $17.4M as of Q2 2026.
  • MUFG Securities EMEA sold 363,292 AbbVie shares in Q2 2026, an estimated $78.2M.
  • AbbVie made up 0.18% of MUFG Securities EMEA's portfolio in Q2 2026, its #96 holding.
  • MUFG Securities EMEA first reported a position in AbbVie in Q2 2015 and has held it in 23 quarters since.
  • MUFG Securities EMEA's AbbVie position peaked at $94.1M in Q1 2026.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.